Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

908 Devices Inc. Director's Dealing 2026

Feb 3, 2026

33342_dirs_2026-02-03_ebf5a9a7-29a1-439a-ac15-1bd65fe48ec4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 908 Devices Inc. (MASS)
CIK: 0001555279
Period of Report: 2026-02-01

Reporting Person: Griffith Joseph H. IV (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-02-01 Common Stock M 5102 Acquired 98032 Direct
2026-02-01 Common Stock M 10306 Acquired 108338 Direct
2026-02-01 Common Stock M 11260 Acquired 119598 Direct
2026-02-01 Common Stock M 43473 Acquired 163071 Direct
2026-02-02 Common Stock S 23175 $6.18 Disposed 139896 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2026-02-01 Restricted Stock Units $ M 5102 Disposed Common Stock (5102) Direct
2026-02-01 Restricted Stock Units $ M 10306 Disposed Common Stock (10306) Direct
2026-02-01 Restricted Stock Units $ M 11260 Disposed Common Stock (11260) Direct
2026-02-01 Restricted Stock Units $ M 43473 Disposed Common Stock (43473) Direct
2026-02-02 Restricted Stock Units $ A 121164 Acquired Common Stock (121164) Direct
2026-02-02 Stock Option (option to buy) $6.19 A 52967 Acquired 2036-02-01 Common Stock (52967) Direct

Footnotes

F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, at settlement, one share of Common Stock. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date.

F2: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.105 to $6.35, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F4: These RSUs vest in four substantially equal annual installments at the four anniversary dates following February 1, 2022, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date.

F5: These RSUs vest in four substantially equal annual installments at the four anniversary dates following February 1, 2023, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date.

F6: These RSUs vest in four substantially equal annual installments at the four anniversary dates following February 1, 2024, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date.

F7: The RSUs shall vest one-third on February 1, 2026, with the remaining two-thirds vesting in two substantially equal annual installments at the two anniversary dates following February 1, 2026, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date.

F8: The RSUs shall vest one-third on February 1, 2027, with the remaining two-thirds vesting in two substantially equal annual installments at the two anniversary dates following February 1, 2027, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date.

F9: One-third of the shares underlying the option become vested and exercisable on February 1, 2027, and the remaining two-thirds of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 24 months following February 1, 2027, subject to the reporting person's continued service through the applicable vesting date.